O steopontin (Opn), a highly acidic phosphoglycoprotein, [1] [2] [3] is constitutively expressed by some renal cells 1, 4, 5 and is upregulated in various animal models of renal disease as well as in human diseases. 6 -12 Osteopontin is a potent modulator of cellular immune response and acts as a chemoattractant for monocytes and T-cells. 13 Therefore, together with monocyte chemoattractant protein 1, it may govern the infiltration of leukocytes observed in the early phase of hypertensive nephrosclerosis.
14 Although the complete function of Opn in the kidney still needs to be defined, proinflammatory as well as cytoprotective effects are postulated. 15 The main function of Opn in healthy adult kidneys appears to be inhibition of urinary stone formation. 16, 17 In various diseases, elevated Opn expression has been shown to propagate renal damage by attracting mononuclear cells into the glomerulus and interstitium. 18 In contrast, Opn can also be regarded as a cytoprotective agent that inhibits synthesis and activity of nitric oxide synthases 19, 20 and protects renal cells from apoptosis after obstructive uropathy. 21 A correlation between increased Opn synthesis and hypertensive tubulointerstitial injury 12 observed in salt-dependent essential hypertension, supports the hypothesis that Opn mediates in part the tubulointerstitial damage occurring during hypertension. The factors that regulate the observed cortical tubular Opn expression need to be defined. In vitro transforming growth factor-␤ and epidermal growth factor 22 have been shown to stimulate renal epithelial cells to synthesize Opn; however, angiotensin II (Ang II), which is highly upregulated during renovascular hypertension, is one of the most potent inducers of Opn synthesis in vivo 11, 23 and in vitro. 24 Therefore, we determined the influence of a blockade of the Ang II receptor type 1 (AT1R) on renal expression of Opn protein and mRNA during the development of hypertensive nephrosclerosis in the Ang II dependent, two-kidney, one-clip (2K1C) model and tried to elucidate whether changes in Opn expression are correlated with mononuclear cell infiltration.
Materials and Methods

Animal Model
Renovascular hypertension was induced in male SpragueDawley rats (Charles River Wiga GmbH, Sulzfeld, Germany), 150 to 180 g, by placing a silver clip (0.20-mm inside diameter) around the left renal artery while the animals were anesthesized by ketamine hydrochloride (5.8 mg/100 g) and xylazine hydrochloride (0.39 mg/100 g). Systolic and mean arterial pressure were determined by femoral artery catheters on the day that the rats were killed. Seven, 14, and 28 days (n ϭ 5 to 10/group) after clipping, the rats were exsanguinated, and kidneys were removed and fixed with methyl-carnoy or paraformaldehyde.
AT1R Blockade
Two weeks after clipping, only those animals with systolic blood pressure (BP) Ͼ150 mm Hg were included in the 2K1C groups. The rats were then treated with the Ang II type 1 receptor antagonist (AT1RA) Valsartan, or placebo. Twelve 2K1C rats received 3 mg/kg/day AT1RA, 27 2K1C rats and 10 sham-operated rats received solvent. Osmotic minipumps (Alzet model 2002, Alza Scientific Products, Palo Alto, CA) that delivered 0.5 L/h for 14 days were implanted under ether anesthesia. Animals were followed up for 14 days, and the surviving rats were killed.
All procedures performed on animals were done in accordance with the National Institutes of Health guidelines and were approved by the local government authorities (Regierung von Mittelfranken, AZ 621-2531.3-10/ 94).
Immunohistochemistry
A mouse antirat Opn antibody (MPIIIB 10 ) was obtained from the Developmental Studies Hybridoma Bank, University of Iowa (Iowa City, IA). Mouse antirat ED-1 antibody (as a marker for monocytes) was from Dako, Hamburg, Germany. Sections (4 m) of methyl-carnoy fixed, paraffin embedded rat kidney sections were dewaxed, rehydrated, and microwave treated. In double staining experiments, using ED-1 (1 g/mL) and Opn (4.5 g/mL) specific monoclonal antibodies, tissue sections were incubated with anti-ED-1 antibody, which was detected by an alkaline phosphatase coupled mouse specific rabbit antibody (Dako). After blocking with mouse immunoglobulins, the sections were incubated with a horseradish peroxidase coupled MPIIIB 10 antibody and counterstained with hematoxylin.
Changes in Opn deposition were semiquantitatively assessed by using a score between 0 and 3 (0 ϭ OSP positive tubules, 1 ϭ up to 5% of tubules per high power section positive for OSP, 2 ϭ up to 20% of tubules positive for OSP, and 3 ϭ Ͼ20% of tubules positive for OSP. The number of ED-1 positive cells was counted in 20 high power sections (ϫ250).
Probes
A 523-bp OPN and a 800-bp glycerin aldehyde phosphate dehydrogenase rat cDNA probe was amplified by RT PCR from serum stimulated or nonstimulated rat mesangial cell total RNA using internal primers of the published sequences. The PCR fragments were cloned into a pCRScript vector (Stratagene, Heidelberg, Germany). Sense and antisense OSP cRNA probes were generated using a RNA digoxygenin labeling kit (Boehringer Mannheim GmbH, Mannheim, Germany). The 32 P-labeled cDNA probes were generated using an Amersham Megaprime kit (Amersham Pharmacia Biotech, Freiburg, Germany).
In Situ Hybridization
Sections (6 m) of formalin fixed, paraffin embedded rat kidney sections were dewaxed, rehydrated, proteinase K treated, dehydrated, and hybridized overnight at 42°C using a hybridization mix containing 50 ng/section digoxigenin labeled riboprobe, 50% deionized formamid, 4ϫSSC,10 g/mL heparin, 25 g/mL yeast t-RNA, 0.2% blocking reagent (Boehringer Mannheim). Both antisense and sense rat Opn digoxigenin labeled cRNAs were detected after RNase A treatment (10 g/mL, 30 min) and stringency wash (0.1ϫSSC) with an alkaline phosphate coupled antidigoxigenin antibody (Dako, Hamburg, Germany) using nitro blue tetrazolium/5-bromo-4-chloroindolyl phosphate as substrate. The sections were counterstained with 0.1% nuclear fast red in 2.5% Al 2 (SO 4 ) 3 . No staining could be detected in control hybridizations using equal amounts of OSP sense cRNA.
Northern Blot
Total RNA was isolated by homogenizing frozen kidneys in cold guanidine isothiocyanate buffer and a subsequent extraction with phenol chloroform. 25 After transfer to a nylon membrane (Biodyne A, Gelman, Ann Arbor, MI), the filters were probed with 32 P-labeled Opn, 18S RNA, or GAPDH cDNA. Opn values were normalized to the GAPDH or 18S RNA signal. Quantification was performed using the ImageJ software, National Institutes of Health (Bethesda, MD).
Statistical Analysis
The differences between the experimental groups were analyzed using a two-tailed Student t test. A P value of Ͻ .05 was considered to be statistically significant.
Results
Development of Hypertension
Moderately elevated mean systolic BP was detectable in 2K1C animals at day 3 138 Ϯ 2.5 mm Hg compared to 122 Ϯ 2.8 mm Hg in sham controls, and was maximally increased up to 224 Ϯ 17 mm Hg compared to 139 Ϯ 2.5 
FIG. 4.
Renal expression of Opn mRNA by in situ hybridization at day 28. In sham operated control animals (A), Opn mRNA is mainly expressed in thin ascending limbs of the outer medulla. Almost no cortical Opn mRNA could be detected (B). In nonclipped kidneys of two-kidney, one-clip (2K1C) rats, Opn mRNA is also detected cortically in a focally defined pattern (D), whereas expression in the medulla is increased (C). A similar expression pattern is seen in the clipped kindeys (F, E). Opn mRNA expression (blue) is colocalized with Opn immunostaining (red) (G). After mRNA detection, Opn protein was immunohistochemically visualized omitting the microwave treatment in citrate buffer. Scale bars represent 100 m. Abbreviations as in Figs. 1-3 .
mm Hg in sham operated controls at day 28. The nonclipped kidneys of hypertensive animals exhibited a progressive tubulointerstitial expansion accompanied initially by focal, and later by widespread, tubular atrophy and dilatation. Starting from day 14, increasing glomerular and arteriosclerotic changes appeared.
After treating the 2K1C animals with 3 mg/kg/day AT1RA, the systolic BP was decreased to 134 Ϯ 8 mm Hg compared to 198 Ϯ 12 mm Hg in 2K1C animals at day 28.
Regulation of Opn Expression
In control animals, Opn expression was observed in thin limbs of the loop of Henle, some distal tubules, and collecting ducts at the outer medulla. Osteopontin was not detected in the renal cortex. In both kidneys of 2K1C animals an increased Opn staining was observed at day 14 in cortex and medulla, which was further increased until day 28 (Fig. 1) . Cortical Opn was focally expressed in dilated distal tubules periglomerular proximal tubules as well as collecting ducts (Fig. 2) . Glomerular Opn staining was solely detectable in Bowman's capsule cells. Osteopontin exhibited an intracellular localization. Treatment with AT1RA had different effects on the Opn expression in the clipped (Fig. 2B, C ) and in the nonclipped (Fig. 2E, F) kidneys of 2K1C rats. Infusion of 3 mg/kg/day AT1RA resulted in a 50% decrease in Opn staining in the nonclipped kidneys of 2K1C rats compared to the 2K1C animals that received solvent. No reduction of Opn staining was observed in the clipped kidneys after AT1RA treatment (Fig. 3) .
The distribution pattern of the Opn protein seen by immunohistochemical staining was confirmed by in situ hybridization (Fig. 4) . Starting from day 14 in nonclipped kidneys, Opn mRNA was expressed de novo in the cortex, in dilated tubules, and in cells of Bowman's capsule. Cortical Opn mRNA was also seen in the clipped ischemic kidneys, although the amount of Opn positive tubules and the intensity of Opn-mRNA signal was less.
Northern blot analysis of total kidney RNA from 2K1C animals and sham-operated controls exhibited a 2.5-fold increase in Opn mRNA in the nonclipped kidney and (1.8-fold) in clipped kidneys of 2K1C animals compared to the control animals (Fig. 5 ).
After treatment with 3 mg/kg/day AT1RA, Valsartan steady state Opn mRNA levels were reduced by 47% in the nonclipped kidney compared to the kidneys of the untreated 2K1C rats. In contrast, Opn steady-state mRNA in the clipped kidneys was not significantly reduced compared to the untreated 2K1C animals ( Table 1) .
Infiltration of ED-1 Positive Cells
During the development of renovascular hypertension, the number of infiltrating ED-1 positive cells increased in nonclipped kidneys (Fig. 6A to F ) and, to a lesser extent, in clipped kidneys of 2K1C rats compared to sham operated control animals. The ED-1 positive cells were concentrated in areas of pronounced tissue damage. Double staining experiments (Fig. 6G, H) exhibited a weak, statistically nonsignificant correlation between the number of Opn expressing tubules and the number of infiltrating tubulointerstitial ED-1 positive cells (Fig. 7A) . In the nonclipped kidneys, treatment with AT1RA reduced the number of the infiltrating interstitial ED-1 positive cells to a level below those of sham operated control animals. In contrast, interstitial monocyte infiltration in the clipped hypoxic kidney was increased, supporting the hypothesis that Opn regulates monocyte infiltration (Fig. 7B) . 
Discussion
The early phase of hypertensive nephrosclerosis is characterized by mononuclear cell infiltration. Osteopontin acts as a chemokine that triggers infiltration of mononuclear cells during various renal inflammatory disease processes. 14, 26 Angiotensin II is among the most potent factors regulating renal osteopontin expression in vivo, 11 which is highly upregulated in the 2K1C model of renovascular hypertension. Therefore, we examined expression and regulation of Opn during 2K1C hypertensive nephrosclerosis, the influence of an altered renal Opn synthesis on the interstitial macrophage infiltration, and the effects Ang II by blocking the Ang II type1 receptor with valsartan.
In kidneys of sham rats, Opn was localized in thin limbs of the loop of Henle in the outer stripe of the renal medulla and weakly in some parietal epithelial cells of Bowman's capsule, as previously reported. 4 After induction of hypertensive nephrosclerosis, Opn was drastically overexpressed in distinct areas of the renal cortex and medulla of 2K1C animals, mainly in proximal and distal tubular cells as well as in parietal epithelial cells of Bowman's capsule of both kidneys.
Because of a highly activated renin-angiotensin-aldosterone system, high levels of Ang II are observed in the 2K1C model. In analogy to various models of renal disease, 6, 11, 27 renal Opn mRNA and protein synthesis may be augmented by Ang II, which is a prosclerotic factor. 11, 24, [27] [28] [29] The prominent role of Ang II as an inductor of Opn expression is supported by data from cultured rat proximal tubular cells exposed to mechanical stretch, in which overexpression of angiotensinogen led to increased Opn synthesis, whereas AT1R antisense oligonucleotides inhibited Opn mRNA expression. 24 However, not all renal cells seem to have the potential to respond to Ang II with increased Opn production. 22 If this is not a cell culture artifact, the observed focal expression of Opn in 2K1C rats may result from the fact that only subsets of tubular cells may have the potential to synthesize Opn in direct response to Ang II. In accordance with the notion that Ang II is the main regulator of Opn synthesis in the 2K1C model, we observed a marked decrease in Opn mRNA levels after AT1R blockade in the nonclipped kidney.
However, in the clipped kidney, additional factors are likely to induce Opn, since treatment with the AT1 receptor antagonist valsartan does not significantly reduce Opn mRNA or protein levels in the clipped kidneys compared to the untreated 2K1C animals.
Ischemic conditions that are present in the clipped kidney 30 -32 have been shown to induce Opn production 33, 34 in other animal models. Decreased perfusion due to the lower BP after AT1R blockade may further increase ischemic damage, which may compensate the inhibition of Ang II effects by valsartan. This may occur by inducing other growth factors and cytokines 35, 36 or by acting directly on Opn transcription.
It is not totally clear whether Opn is synthesized to protect cells from ischemic damage, or whether the increased Opn protein acts as an inflammatory mediator. Renal dysfunction was twofold higher in mice with targeted disruption of the Opn gene compared to control animals with the intact Opn gene after renal ischemia. Because mice lacking Opn expressed higher levels of inducible nitric oxide synthase, 37 one may speculate that synthesis of Opn is cytoprotective by inhibiting NO production.
In contrast, Opn mediates multiple inflammatory processes, 13 favoring a T helper-1 cell mediated immune response or, in some conditions, being necessary for antigen challenged dendritic cells to migrate to the lymph nodes. 38 Although there are still conflicting data from Opn knockout mice, 39 in most animal models of renal diseases and in several human renal diseases, Opn can be correlated with mononuclear cell infiltration. 11,37,40 -44 Our data suggest an important role of Opn as chemoattractant during nephrosclerosis in 2K1C hypertension. In the nonclipped kidney AT1R blockade led to a reduction in Opn mRNA levels, which may account for the observed reduction in mononuclear cell infiltration. This notion is supported by the observation that in the clipped kidney, where Opn mRNA is still elevated after AT1R blockade, a massive infiltration of ED-1 positive mononuclear cells is notable.
Although we could not detect a significant spatial correlation between mononuclear infiltration and Opn expression, the marked correlation between Opn production and the number of macrophages in the clipped kidney after AT1R blockade suggests an important role of Opn in the regulation of mononuclear cell infiltration. The factors regulating the Opn synthesis and perhaps, thereby, mononuclear cell infiltration seem to be different in the clipped and nonclipped kidney. Although Ang II appears to be the main regulator of Opn synthesis in the nonclipped kidney, other factors induced by hypoxia should be considered to act in the clipped kidney during 2K1C hypertension.
